Skip to main content
. 2019 Jun 27;146(7):1791–1799. doi: 10.1002/ijc.32512

Table 3.

Numbers of family members of the proband, number of observed cancer cases and standardized incidence ratios (SIR) for early‐onset (≤40 years) concordant cancer in siblings of the proband by concordant parental cancer at any age

Relatedness to the proband Number of family members of the proband Number of cancers Person‐years SIR for concordant cancer1 (95% CI)
Brain and other CNS cancers2
Sibling with affected parent3 194 6 3,954 29 (11–64)
Sibling without affected parent4 10,458 18 196,353 1.80 (1.06–2.84)
Breast cancer2
Sibling with affected parent3 980 10 15,226 10 (4.85–19)
Sibling without affected parent4 8,513 33 137,842 4.14 (2.85–5.81)
Colorectal cancer2
Sibling with affected parent3 363 10 6,405 905 (43–165)
Sibling without affected parent4 3,392 6 59,233 5.29 (1.94–12)
Melanoma2
Sibling with affected parent3 193 0 3,414 0.00 (0.00–30)
Sibling without affected parent4 5,145 7 84,220 2.23 (0.90–4.60)
1

SIR (95% CI) for concordant cancer in the family member of the proband.

2

According to pathological reports retrieved from the Finnish Cancer Registry for siblings with affected parents, all brain and CNS cases were in families with neurofibromatosis in at least one subjects with diagnosed cancer. We found no record of BRCA carriers among breast cancer probands and their siblings or parents. FAP or HNPCC was found in four of the 10 multiplex colorectal cancer families.

3

At least one sibling diagnosed with the concordant cancer at age ≤40 years and at least either one of the parents diagnosed with the concordant cancer at any age. There were no families with both affected parents.

4

At least one sibling diagnosed with the concordant cancer at age ≤40 years, no parents with concordant cancer.

5

SIR for the families without FAP or HNPCC was 56 (21–122).